Convalescent plasma therapy - a silver lining for COVID-19 management?
The COVID-19 pandemic has pushed the world towards social, economic, and medical challenges. Scientific research in medicine is the only means to overcome novel and complex diseases like COVID-19. To sum up the therapeutic wild-goose chase, many available antivirals and repurposed drugs have failed...
Main Authors: | Sumit Saha, Sachin Kadam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137921000547 |
Similar Items
-
The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01) -
Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
by: Douglas Tremblay, et al.
Published: (2020-11-01) -
Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study
by: Adam Tworek, et al.
Published: (2021-04-01) -
Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19—An exploratory study
by: Vinod Jaiswal, et al.
Published: (2021-01-01) -
The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
by: Livius Tirnea, et al.
Published: (2021-03-01)